![Diagnosing Health Care Podcast artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts114/v4/c4/f8/3a/c4f83a60-acdf-caf3-1b0b-dbc2c0a79cd1/mza_13230586137393811055.jpg/100x100bb.jpg)
Key Considerations for Reshoring U.S. Drug Manufacturing
Diagnosing Health Care Podcast
English - October 13, 2020 14:59 - 27 minutes - 25.3 MBMedicine Health & Fitness Science Life Sciences management attorney business compliance healthcare lawfirm lawyer legal lifesciences policy Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Today’s episode looks at the key business, policy, and legal considerations for reshoring active pharmaceutical ingredient (or “API”) and finished drug product manufacturing to the United States. The episode features Members of the Firm Delia Deschaine and Neil Di Spirito and is hosted by attorney Bonnie Scott.
Visit our site for more information and related resources: https://www.ebglaw.com/dhc10
Subscribe for email notifications: https://www.ebglaw.com/subscribe
Visit: http://diagnosinghealthcare.com
The EMPLOYMENT LAW THIS WEEK® and DIAGNOSING HEALTH CARE podcasts are presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.